124 related articles for article (PubMed ID: 2262932)
1. Binding characteristics of the muscarinic receptor subtype in rabbit pancreas.
van Zwam AJ; Willems PH; Rodrigues de Miranda JF; de Pont JJ; van Ginneken CA
J Recept Res; 1990; 10(1-2):119-35. PubMed ID: 2262932
[TBL] [Abstract][Full Text] [Related]
2. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
Yang CM; Farley JM; Dwyer TM
J Auton Pharmacol; 1986 Mar; 6(1):15-24. PubMed ID: 3957950
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cholinergic muscarinic receptors in the rabbit iris.
Honkanen RE; Abdel-Latif AA
Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
[TBL] [Abstract][Full Text] [Related]
6. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
9. Characterization of muscarinic receptors in rat kidney.
Blankesteijn WM; Siero HL; Rodrigues de Miranda JF; van Megen YJ; Russel FG
Eur J Pharmacol; 1993 Jan; 244(1):21-7. PubMed ID: 8420789
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptors in canine colonic circular smooth muscle. I. Coexistence of M2 and M3 subtypes.
Zhang LB; Horowitz B; Buxton IL
Mol Pharmacol; 1991 Dec; 40(6):943-51. PubMed ID: 1758444
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
Haddad EB; Landry Y; Gies JP
Mol Pharmacol; 1990 May; 37(5):682-8. PubMed ID: 1692606
[TBL] [Abstract][Full Text] [Related]
12. Characterization of muscarinic receptor subtypes on rat pancreatic acini: pharmacological identification by secretory responses and binding studies.
Kato M; Ohkuma S; Kataoka K; Kashima K; Kuriyama K
Digestion; 1992; 52(3-4):194-203. PubMed ID: 1281128
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
15. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
Messer WS; Ellerbrock BR; Smith DA; Hoss W
J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
17. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
Munns M; Pennefather JN
Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
[TBL] [Abstract][Full Text] [Related]
19. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.
Fryer AD; el-Fakahany EE
Life Sci; 1990; 47(7):611-8. PubMed ID: 2402185
[TBL] [Abstract][Full Text] [Related]
20. Binding of muscarine receptor antagonists to pig coronary smooth muscle.
Rinner I; Doods HN; van Charldorp KJ; Davidesko D; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):146-50. PubMed ID: 3368018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]